Aims and Scope
The Journal of Alzheimer's Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.
The primary means of submission is through mstracker.com
. The authors should identify an Associate Editor with expertise in the scope of the manuscript. The Associate Editor will be responsible for identifying reviewers and, after receiving reviews, for making a recommendation on the acceptability of the manuscript for publication. All final decisions on acceptability will be made by the Editor-in-Chief. The Associate Editors will be listed in the article as the Handling Associate Editor. Corresponding authors of accepted articles may be invited to join JAD as Associate Editors. See Information for Authors for details.
The Journal of Alzheimer’s Disease
is a member of the Neuroscience Peer Review Consortium
. The Consortium is an alliance of neuroscience journals that have agreed to accept manuscript reviews from each other.
JAD has an Impact Factor of 3.517 [2018 Journal Citation Reports (Web of Science Group, 2019)], an h-index of 110 (Web of Science), an h-index of 115 (2018 SCImago Journal Rank indicator), a CiteScore of 3.66 (Scopus), an h5-index of 68 (Google Scholar), and an h5-median of 93 (Google Scholar).
- Academic Source Complete
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CAB Health
- Chemical Abstracts Service (CAS)
- CSA Biological Sciences
- CSA Illumina
- CSA Illustrata Natural Sciences
- CSA Neurosciences Abstracts
- e-psyche database
- EBSCO database
- Index Copernicus
- Index Medicus
- Journal Citation Reports/Science Edition
- Prous Science Integrity
- Science Citation Index Expanded (SciSearch)
- Ulrich's Periodicals Directory
JAD's targeted audience is comprised of basic science researchers and clinicians in the areas of Alzheimer's disease and related disorders.
News & Social Media
View a selection of newsletters that were sent out recently by clicking on the links:
During 2018, JAD celebrates its 20th anniversary
and we invite you to view the special message (here
) about the journal's 20 years from Editor-in-Chief George Perry. An open access celebratory issue
was published as JAD 62:3. Read about the issue here
, or view the content at: tiny.cc/JAD-anniv
. The anniversary issue pays tribute to those who have contributed to JAD and then, we look forward to what lies in store to the next years of AD research, in our new book Alzheimer's Disease: New Beginnings
. We also published a special commemorative publication that can be viewed online here
For the current cover (2004-present), JAD editors chose Casey Reas, an artist and educator exploring abstract kinetic systems through diverse digital media including software, animation, and digital prints. Casey's cover for JAD was generated from software written specifically for the journal. It generates thousands of flower-like images and from these many variations, Casey selected the cover image. The chosen form and color are a reference to the magnolia flower of Darryl Evan’s cover illustration (1999-2003) of Hippocrates, where the flying pieces of the Alzheimer's puzzle and steel magnolia symbolize the one out of the sixteen Americans who stand behind each Alzheimer's victim. And so with this motif, the two covers, past and present, link and illustrate the continuance in JAD's mission to deliver top-quality science.
The book series "Advances in Alzheimer's Disease" brings together the latest insights in Alzheimer’s disease research in specific areas in which major advances have been made. It assembles and builds on work recently published in JAD, and also includes further contributions to ensure comprehensive coverage of the topic. The emphasis is on the development of novel approaches to understanding and treating Alzheimer’s and related diseases. Find out more at: tiny.cc/AIAD
IOS Press serves the information needs of scientific and medical communities worldwide. IOS Press publishes more than 100 international journals and approximately 75 book titles each year
on subjects ranging from computer sciences and mathematics to medicine and natural sciences.
Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.
All journals are available in print and electronic format.